GLIVANCE XR 500 MG + 30 MG COM LIB PROL CT BL AL PLAS PVDC TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1008904040012 -
GGREM
525418100050005 -
Código de barras
7891721029950
O que a fonte publica
- Detentor do registro
- MERCK S/A
- Princípios ativos
- CLORIDRATO DE METFORMINA;GLICLAZIDA
- Embalagem
- 500 MG + 30 MG COM LIB PROL CT BL AL PLAS PVDC TRANS X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- A10J2 - ASSOCIAÇÕES DE ANTIDIABÉTICOS SULFONILOURÉIA COM BIGUANIDAS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- GLIVANCE XR 500 MG + 30 MG COM LIB PROL CT BL AL PLAS PVDC TRANS X 30
- GLIVANCE XR
- CLORIDRATO DE METFORMINA
- GLICLAZIDA
Dados completos da fonte
{
"name": "GLIVANCE XR 500 MG + 30 MG COM LIB PROL CT BL AL PLAS PVDC TRANS X 30",
"holder": "MERCK S/A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891721029950"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "525418100050005",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.069.212/0001-84",
"priceRegime": "Regulado",
"productName": "GLIVANCE XR",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "500 MG + 30 MG COM LIB PROL CT BL AL PLAS PVDC TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "35.47",
"icms-12": "40.31",
"icms-17": "42.73",
"icms-18": "43.26",
"icms-19": "43.79",
"icms-20": "44.34",
"icms-21": "44.90",
"icms-22": "45.47",
"icms-23": "46.06",
"icms-17.5": "42.99",
"icms-19.5": "44.06",
"icms-20.5": "44.62",
"icms-22.5": "45.77",
"icms-12-alc": "35.99",
"icms-17-alc": "38.16",
"icms-18-alc": "38.62",
"icms-19-alc": "39.10",
"icms-20-alc": "39.59",
"icms-21-alc": "40.09",
"icms-22-alc": "40.60",
"icms-23-alc": "41.13",
"withoutTaxes": "31.67",
"icms-17.5-alc": "38.39",
"icms-19.5-alc": "39.34",
"icms-20.5-alc": "39.84",
"icms-22.5-alc": "40.86"
},
"pisCofinsList": "Negativa",
"substanceText": "CLORIDRATO DE METFORMINA;GLICLAZIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "47.58",
"icms-12": "54.07",
"icms-17": "57.32",
"icms-18": "58.03",
"icms-19": "58.74",
"icms-20": "59.48",
"icms-21": "60.23",
"icms-22": "61.00",
"icms-23": "61.79",
"icms-17.5": "57.67",
"icms-19.5": "59.10",
"icms-20.5": "59.86",
"icms-22.5": "61.40",
"icms-12-alc": "49.75",
"icms-17-alc": "52.75",
"icms-18-alc": "53.39",
"icms-19-alc": "54.05",
"icms-20-alc": "54.73",
"icms-21-alc": "55.42",
"icms-22-alc": "56.13",
"icms-23-alc": "56.86",
"withoutTaxes": "43.78",
"icms-17.5-alc": "53.07",
"icms-19.5-alc": "54.39",
"icms-20.5-alc": "55.08",
"icms-22.5-alc": "56.49"
},
"invalidBarcodes": [],
"activeSubstances": [
"CLORIDRATO DE METFORMINA",
"GLICLAZIDA"
],
"therapeuticClass": "A10J2 - ASSOCIAÇÕES DE ANTIDIABÉTICOS SULFONILOURÉIA COM BIGUANIDAS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1008904040012",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10J2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:525418100050005"